Inogen announces changes to board
By HME News Staff
Updated 11:57 AM CST, Mon January 3, 2022
GOLETA, Calif. – Inogen has announced that Elizabeth Mora has been elected as chairperson of its board of directors. She has served as a member of the board since May 24, 2021, and is also a member of the Audit Committee and Compliance Committee. She assumes the role of Heath Lukatch, Ph.D., who has served as chairperson since 2008. “As we continue to evolve Inogen, including recent changes we have made to our executive team, these alterations to the board are consistent with our goal of transforming Inogen into a more prominent player in respiratory care,” Lukatch said. “Beth’s leadership and operational experience at world-leading research institutions, combined with her track record on public company boards, including serving as a chair of several audit committees, will be instrumental in leading the Board and continuing Inogen’s growth.” Lukatch will remain on the board as a director and as a member of the Compensation Committee. Additionally, Inogen has announced that Ray Huggenberger, a former CEO who has served on the board since 2008, is retiring from the board and transitioning to an advisory role. Mora will replace Huggenberger as chairperson of the Compliance Committee. Following Huggenberger’s retirement, the board has been reduced to seven members.
Comments